What's breaking now, across thousands of outlets.
Nothing is certain in clinical trials, but investors have reason to expect a better outcome in the oral VK2735 trials.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Commerzbank’s Thu Lan Nguyen analyzes EUR/USD’s sharp decline since September, initially driven by broad US Dollar strength and later by Euro-specific concerns over France’s public finances.
CBA chief economist Luke Yeaman has written a report warning that Australia is approaching the most difficult phase of the inflation battle.
B2B payments company Boost Payments Solutions has launched a partnership with financial operating system Airwallex. The collaboration is designed to enhance Boost’s international commercial card…
The company supports drug developers from early development through GMP manufacturing and clinical trials, and built the RFP>Navigator outsourcing platform.
The Lead the Future Conference 2026, a leadership convening for visionary founders, executives and institutional leaders shaping future-ready organisations, will hold on October 23 and 24, 2026, at…
The Swiss regulator cited a growing appetite for cryptocurrency investments and said that multiple fund providers have submitted Bitcoin ETF applications.
